An accelerated discovery pipeline for antiviral antibody therapeutics
12 Nov 2019
Viral infectious diseases are emerging and re-emerging globally, which underscores the urgent need for accelerated discovery of antiviral therapeutics. Human antiviral monoclonal antibodies (mAbs) are promising drug candidates for clinical evaluation. High cost and long timelines required to develop therapeutic mAbs remain two of the key challenges.
Join our free educational webinar to learn how researchers have implemented accelerated discovery and validation of potent therapeutic mAbs using an integrated pipeline technology combining flow cytometry, bioinformatics, synthetic biology, and high-throughput analysis.
Key Learning Objectives:
Who Should Attend:
- Gain insight into flow cytometry, bioinformatics, and synthetic biology techniques used for mAb discovery and validation
- Understand the workflow for accelerating mAb therapeutics for use as antiviral agents
This webinar will provide insights for researchers who want to learn how integrated approaches can be implemented for efficiently accelerating therapeutic mAb discovery and validation.Certificate of Attendance
All webinar participants can request a certificate of attendance, and a learning outcomes summary document for continuing education purposes.Sony Biotechnology